BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36966045)

  • 1. Corrigendum to "Chlorambucil-conjugated PI-polyamide (Chb-M'), a transcription inhibitor of the RUNX family, has anti-tumor activity against SHH-type medulloblastoma with p53 mutation" [Biochem. Biophys. Res. Commun. 620 (10 September 2022) 150-157].
    Matsui Y; Mineharu Y; Noguchi Y; Hattori EY; Kubota H; Hirata M; Miyamoto S; Sugiyama H; Arakawa Y; Kamikubo Y
    Biochem Biophys Res Commun; 2023 May; 656():146-147. PubMed ID: 36966045
    [No Abstract]   [Full Text] [Related]  

  • 2. Chlorambucil-conjugated PI-polyamides (Chb-M'), a transcription inhibitor of RUNX family, has an anti-tumor activity against SHH-type medulloblastoma with p53 mutation.
    Matsui Y; Mineharu Y; Noguchi Y; Hattori EY; Kubota H; Hirata M; Miyamoto S; Sugiyama H; Arakawa Y; Kamikubo Y
    Biochem Biophys Res Commun; 2022 Sep; 620():150-157. PubMed ID: 35792512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RUNX inhibitor suppresses graft-versus-host disease through targeting
    Kubota H; Masuda T; Noura M; Furuichi K; Matsuo H; Hirata M; Kataoka TR; Hiramatsu H; Yasumi T; Nakahata T; Imai Y; Takita J; Adachi S; Sugiyama H; Kamikubo Y
    EJHaem; 2021 Aug; 2(3):449-458. PubMed ID: 35844683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Alkylation of the RUNX-Binding Sequence by CBI-PI Polyamide Conjugates*.
    Maeda R; Ito S; Hashiya K; Bando T; Sugiyama H
    Chemistry; 2020 Nov; 26(64):14639-14644. PubMed ID: 32672369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chb-M', an Inhibitor of the RUNX Family Binding to DNA, Induces Apoptosis in
    Hirose Y; Sato S; Hashiya K; Ooga M; Bando T; Sugiyama H
    J Med Chem; 2024 May; ():. PubMed ID: 38803164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of malignant rhabdoid tumors through Chb-M'-mediated RUNX1 inhibition.
    Daifu T; Mikami M; Hiramatsu H; Iwai A; Umeda K; Noura M; Kubota H; Masuda T; Furuichi K; Takasaki S; Noguchi Y; Morita K; Bando T; Hirata M; Kataoka TR; Nakahata T; Kuwahara Y; Iehara T; Hosoi H; Takita J; Sugiyama H; Adachi S; Kamikubo Y
    Pediatr Blood Cancer; 2021 Feb; 68(2):e28789. PubMed ID: 33180377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum to "Functional loss of TAGLN inhibits tumor growth and increases chemosensitivity of non-small cell lung cancer" [Biochem. Biophys. Res. Commun. 529 (4) (3 September 2020) 1086-1093].
    Fu J; Wang X; Yue Q
    Biochem Biophys Res Commun; 2021 Feb; 541():102. PubMed ID: 33478719
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to 'The C-terminus of ubiquitin plays a critical role in deamidase Lpg2148 recognition.' [Biochem. Biophys. Res. Commun. 503(4), 18 September 2018, 2943-2948].
    Zhu M; Ma X; Gao Y; Li X; Ke J; Khan MH; Teng M; Ge H; Zhu Z; Niu L
    Biochem Biophys Res Commun; 2018 Oct; 505(2):633. PubMed ID: 30243727
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling" [Biochem. Biophys. Res. Commun. 524 (1) (2020) 1-7].
    Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
    Biochem Biophys Res Commun; 2021 Jan; 536():115. PubMed ID: 33390248
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to 'Revisit the effect of fibrillization on functions of prion protein from the perspective of Cu(II) binding' [Biochem. Biophys. Res. Commun. vol. 503 (1) (3 September 2018) 32-37].
    Qi X; McGuirl M
    Biochem Biophys Res Commun; 2018 Sep; 504(1):359. PubMed ID: 30139520
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "TTK inhibitor promotes radiosensitivity of liver cancer cells through p21" [Biochem. Biophys. Res. Commun. 550(2021) 84-91].
    Zhang H; Yao W; Zhang M; Lu Y; Tang J; Jiang M; Mou X; You G; Liang X
    Biochem Biophys Res Commun; 2021 May; 555():214. PubMed ID: 33840464
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Structure-based molecular characterization of the LltR transcription factor from Listeria monocytogenes" [Biochem. Biophys. Res. Commun. 600(2022) 142-149].
    Kim J; Park J; Choi Z; Hong M
    Biochem Biophys Res Commun; 2022 Jun; 609():197. PubMed ID: 35487771
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to ‟Autophagy prevention sensitizes AKTi-1/2-induced anti-hepatocellular carcinoma cell activity in vitro and in vivo" [Biochem. Biophys. Res. Commun. (2016) 480(3) 334-340].
    Zhang Q; Yang M; Qu Z; Zhou J; Jiang Q
    Biochem Biophys Res Commun; 2021 Aug; 565():99. PubMed ID: 33962803
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "The SIRT2 inhibitor AK-7 decreases cochlear cell apoptosis and attenuates noise-induced hearing loss" [Biochem. Biophys. Res. Commun. 509 (3) (2019) 641-646].
    Liu Y; Ao L; Li Y; Zhao Y; Wen Y; Ding H
    Biochem Biophys Res Commun; 2019 Mar; 511(1):201. PubMed ID: 30773260
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "A novel firefly luciferase biosensor enhances the detection of apoptosis induced by ESAT-6 family proteins of Mycobacterium tuberculosis" [Biochem. Biophys. Res. Commun. 452 (4) (2014) 1046-1053].
    Shi J; Zhang H; Fang L; Xi Y; Zhou Y; Luo R; Wang D; Xiao S; Chen H
    Biochem Biophys Res Commun; 2020 Feb; 522(4):1069-1070. PubMed ID: 31952792
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Progranulin protects against cerebral ischemia-reperfusion (I/R) injury by inhibiting necroptosis and oxidative stress" [Biochem. Biophys. Res. Commun. 521 (315) (2020) 569-576].
    Li X; Cheng S; HaoHu ; Zhang X; JiehuaXu ; Wang R; Zhang P
    Biochem Biophys Res Commun; 2020 May; 525(3):822. PubMed ID: 32171520
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "β-arrestins negatively control human adrenomedullin type 1-receptor internalization" [Biochem. Biophys. Res. Commun. 487 (2) (2017) 438-443].
    Kuwasako K; Kitamura K; Nagata S; Sekiguchi T; Jiang D; Murakami M; Hattori Y; Kato J
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1139. PubMed ID: 28610829
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Modelling urea-cycle disorder citrullinemia type 1 with disease-specific iPSCs" [Biochem. Biophys. Res. Commun. 486(3) (2017) 613-619].
    Yoshitoshi-Uebayashi EY; Toyoda T; Yasuda K; Kotaka M; Nomoto K; Okita K; Yasuchika K; Okamoto S; Takubo N; Nishikubo T; Soga T; Uemoto S; Osafune K
    Biochem Biophys Res Commun; 2017 Jul; 488(3):570-571. PubMed ID: 28528898
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Cell type-specific roles of Jak3 in IL-2-induced proliferative signal transduction" [Biochem. Biophys. Res. Commun. 354 (3) (2007) 825-829].
    Fujii H
    Biochem Biophys Res Commun; 2021 May; 552():196. PubMed ID: 33722377
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Netrin-1 promotes metastasis of gastric cancer by regulating YAP activity" [Biochem. Biophys. Res. Commun. 496 (1) (2018 Jan 29) 76-82].
    Yin K; Dang S; Cui L; Fan X; Xie R; Qu J; Shang M; Chen J
    Biochem Biophys Res Commun; 2018 Mar; 498(1):262. PubMed ID: 29506865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.